tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michelle Gilson, 64 are a BUY (94.12%), 4 are a HOLD (5.88%).
Analyst Michelle Gilson, carries an average stock price target met ratio of 46.15% that have a potential upside of 24.24% achieved within 201 days. Previously, Michelle Gilson worked at MORGAN STANLEY, OPPENHEIMER, CANACCORD.
Michelle Gilson’s has documented 131 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VIR, Vir Biotechnology at 11-Jun-2026.
Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 9/16/2016. The price target of $60 was fulfilled within 6 days with a profit of $31.85 (113.14%) receiving and performance score of 188.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Sep-2024
$312
$48.48 (18.40%)
$262
12 days ago
(02-Sep-2026)
14/15 (93.33%)
$44.69 (16.72%)
921
Buy Since 03-Jul-2025
$273
$9.48 (3.60%)
$275
13 days ago
(01-Sep-2026)
1/3 (33.33%)
$12.75 (4.90%)
357
Buy Since 02-May-2025
$327
$63.48 (24.09%)
$273
13 days ago
(01-Sep-2026)
4/5 (80%)
$66.75 (25.65%)
102
Buy Since 31-May-2024
$326
$62.48 (23.71%)
$256
14 days ago
(31-Aug-2026)
5/6 (83.33%)
$62.96 (23.94%)
271
Buy Since 11-Jan-2024
$330
$66.48 (25.23%)
$290
14 days ago
(31-Aug-2026)
5/7 (71.43%)
$66.96 (25.46%)
327
Which stock is Michelle Gilson most bullish on?
